Former clinical-stage biopharmaceutical company (Apitox, a non-opioid bee-venom pain therapy) that became a Digital Asset Treasury company through its December 1, 2025 reverse merger with MindWave Innovations Inc. The merger brought approximately 1,000 bitcoin onto the balance sheet (contributed by MindWave and acquired with Series A convertible preferred and common stock consideration), alongside USDT and MindWaveDAO NILA tokens. The bitcoin is held in a segregated, risk-managed structure under an AI-driven yield-generation strategy, while the legacy biotech operations are being transferred to a subsidiary (Lokahi Therapeutics).
| Instrument | Term | Coupon | Principal | Outstanding | Conv. price | BTC Rating |
|---|---|---|---|---|---|---|
| APUS-Dec26 | Dec '25 – Dec '26 | 0% | 10.90M USD | 10.90M USD | — | 6.4x |
| Total | 10.90M USD | |||||
Tracker figure (current point, newer than latest filing).
BTC Holdings TrackerDerived from BTC fair value of $66,552,480; company discloses BTC at fair value only (no unit count). Digital assets also include USDT and NILA tokens.
Form 10-Q (Q1 2026)Outstanding balance as reported.
Form 10-Q (Q1 2026)Cash and cash equivalents; excludes $8.0M restricted DACA cash.
Form 10-Q (Q1 2026)Cash and cash equivalents; excludes $8.0M restricted DACA cash.
Form 10-Q (Q1 2026)